Multipolar Radiofrequency Treatment for Meibomian Gland Dysfunction: A Prospective Randomized Controlled Trial
MedComm · 2026-12 · 7 (12)
DOI: 10.1002/mco2.71157 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift MedComm, online erschienen am 20.11.2026. Verfasst von Ya Wen und 8 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Capital Health Research and Development of Special Fund.
Abstract (Originalsprache)
This single‐center, prospective, randomized controlled study evaluated the efficacy and safety of a novel multipolar radiofrequency (RF) device in treating meibomian gland dysfunction (MGD). Patients diagnosed with MGD were randomly assigned to the RF treatment group ( n = 21) or warm compress group ( n = 20), and participants received four weekly 20‐min sessions of either RF or warm compress treatment. The Ocular Surface Disease Index (OSDI) and Visual Analogue Scale (VAS) scores were used to assess symptoms. The primary efficacy indices included meibomian gland expressibility, meibum quality (MQ) score, fluorescein tear break‐up time (FBUT), and total corneal fluorescein staining (CFS) score, while the secondary efficacy indices included meibomian gland dropout, non‐invasive tear break‐up time (NIBUT), Schirmer I test (SIT), tear meniscus height (TMH), and lipid layer thickness (LLT). Both interventions improved symptoms; at the final follow‐up, the RF group had lower symptom scores than the warm compress group ( p ≤ 0.05). Meibomian gland expressibility scores were also lower in the RF group ( p ≤ 0.05). NIBUT and LLT were significantly higher in the RF group ( p ≤ 0.05). No serious adverse events were observed. In conclusion, multipolar RF showed short‐term efficacy and safety in MGD patients.
Förderung
- Capital Health Research and Development of Special Fund
Zitieren
APA
Wen, Y., Chen, X., Wen, H., Wu, B., Wu, Q., Dai, C., Liu, J., Tian, L., & Jie, Y. (2026). Multipolar Radiofrequency Treatment for Meibomian Gland Dysfunction: A Prospective Randomized Controlled Trial. MedComm, 7(12). https://doi.org/10.1002/mco2.71157
Vancouver
Wen Y, Chen X, Wen H, Wu B, Wu Q, Dai C, et al. Multipolar Radiofrequency Treatment for Meibomian Gland Dysfunction: A Prospective Randomized Controlled Trial. MedComm. 2026;7(12). doi:10.1002/mco2.71157
BibTeX
@article{Wen2026,
author = {Wen, Ya and Chen, Xiaoniao and Wen, Haonan and Wu, Binge and Wu, Qianru and Dai, Chang and Liu, Jing and Tian, Lei and Jie, Ying},
title = {Multipolar Radiofrequency Treatment for Meibomian Gland Dysfunction: A Prospective Randomized Controlled Trial},
journal = {MedComm},
year = {2026},
volume = {7},
number = {12},
doi = {10.1002/mco2.71157}
}
EUVIMED